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Abstract
Heart failure is a common endpoint for many forms of cardiovascular disease and a significant cause of morbidity and mortality. 
Chronic neurohumoral excitation (i.e., sympathetic hyperactivity) has been considered to be a hallmark of heart failure and is as-
sociated with a poor prognosis, cardiac dysfunction and remodeling, and skeletal myopathy. Aerobic exercise training is efficient 
in counteracting sympathetic hyperactivity and its toxic effects on cardiac and skeletal muscles. In this review, we describe the 
effects of aerobic exercise training on sympathetic hyperactivity, skeletal myopathy, as well as cardiac function and remodeling 
in human and animal heart failure. We also discuss the mechanisms underlying the effects of aerobic exercise training.
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Heart failure (HF) is a syndrome of poor prognosis 
and high health care costs (1) characterized by dysp-
nea and exercise intolerance as a consequence of low 
cardiac output. It is a common endpoint for many forms 
of cardiovascular diseases. More than 20 million people 
worldwide are estimated to have HF (1), and this situ-
ation is more critical considering that the prevalence of 
HF will rise as the mean age of the population increases. 
The development of HF involves a continuous interaction 
between myocardial dysfunction and a compensatory 
activation of neurohumoral systems such as sympathetic 
and renin-angiotensin-aldosterone hyperactivity to name 
a few (2). At first, this response is compensatory, but 
sustained neurohumoral hyperactivity is toxic (3,4) and 
portends a poor prognosis (5). HF treatment aims to 
improve prognosis and control symptoms by blocking 
neurohumoral hyperactivity with the use of β-adrenoceptor 
blockers, inhibitors of angiotensin-converting enzyme 
(ACE), angiotensin II receptor blockers and inhibitors of 
aldosterone synthesis, and by controlling fluid retention 
(6). Even though neurohumoral blockade is associated 
with a better prognosis (7), reversal remodeling (4,8,9) 
and improved cardiac calcium handling (9), HF remains 
a major cause of illness and death. Thus, new strategies 
for HF treatment and prevention are among the great 
challenges facing health sciences today. 
In patients with stable HF, exercise training can relieve 
symptoms, improve exercise tolerance and quality of life, 
and reduce hospitalization (10). In addition, current treat-
ment guidelines recommend aerobic exercise training to 
HF patients in functional classes II and III according to the 
New York Heart Association (11). 
In the present review, we discuss the effects of aero-
bic exercise training on HF with focus on neurohormonal 
hyperactivity and its toxic effects on cardiac and skeletal 
muscles.
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Effects of exercise training on the 
sympathetic nervous system
The beneficial effects of exercise training in HF are as-
sociated with neural control of the cardiovascular system 
(12,13). These effects include reduction of sympathetic 
outflow in exercised humans (14,15) and animals (16-18) 
with HF. The sympathetic toxicity of cardiac (17-21) and 
skeletal (22-24) muscles in HF is also reduced by exercise 
training. Since morbidity and mortality in cardiovascular 
disease are often associated with increases of sympathetic 
nerve activity, exercise training becomes a potent non-
pharmacological strategy for HF therapy. 
Coats et al. (25) were the first to report that exercise 
training changes the parasympathetic/sympathetic balance. 
Exercise training reduced by 16% whole-body radiolabeled 
norepinephrine spillover in HF patients (26). Additionally, 
these investigators also observed an enhanced parasym-
pathetic control of heart rate paralleled by a decreased 
sympathetic dominance in exercised HF patients. This is 
particularly interesting since parasympathetic dysfunction 
parallels sympathetic hyperactivation in HF (27). Therefore, 
HF therapies that increase cholinergic activity (28) and/or 
decrease adrenergic hyperactivity (9) should combine exer-
cise training to optimize the benefits on the cardiovascular 
system. In this context, we have demonstrated an additional 
reduction in muscular sympathetic nerve activity by exercise 
training in HF patients optimized with carvedilol, a third gen-
eration β-blocker (β1- and β2-blockade) with an α-blockade 
and vasodilatory effect (14). Additionally, while β-blocker 
therapy had no impact on exercise capacity in humans or 
animals with HF (6,9), a β-blocker combined with exercise 
training improved exercise capacity (14,19). 
The reduction of sympathetic activity by exercise training 
in HF patients is associated with a better clini-
cal outcome (14,15). We have demonstrated 
by direct assessment of muscular sympathetic 
nerve activity that a 4-month period of moderate 
exercise training leads to a significant reduction 
in resting sympathetic activity (Figure 1) associ-
ated with improved peak oxygen uptake and 
exercise tolerance in class II and III New York 
Heart Association chronic HF patients (15). 
It is important to emphasize that the sympa-
thetic activity was so dramatically reduced by 
exercise training that it returned to the values 
of age-matched, healthy controls.
The mechanisms underlying reduced 
sympathetic nerve activity by exercise training 
are still a topic of major interest under current 
investigation. One of the potential candidates 
for sympathetic reduction by exercise training 
is the afferent autonomic control of sympa-
thetic nerve activity coordinated by arterial 
baroreceptors, cardiopulmonary receptors, 
ergoreceptors, and chemoreceptors (29-35). 
We have demonstrated that exercise training reduces 
renal sympathetic nerve activity associated with increased 
arterial baroreceptor afferent sensitivity in control rats 
(29,31). Interestingly, this knowledge was extended to 
HF by Liu et al. (30), who observed reestablished arterial 
baroreflex control to heart rate and renal sympathetic nerve 
activity by exercise training in a rabbit model of pacing-
induced HF. The same investigators also demonstrated 
that this response was mainly parasympathetic-mediated 
since atropine blocked the improved baroreflex control of 
heart rate by exercise training (36). In addition, we also 
demonstrated that improved baroreflex control of renal 
sympathetic nerve activity in a rat model of myocardial 
infarction was associated with increased aortic depressor 
nerve sensitivity (13). 
Exercise training also exerts important effects on 
chemoreflex and cardiopulmonary reflex (35). Enhanced 
chemoreflex control was decreased by exercise training in 
a rabbit model of HF (34). Conversely, depressed cardio-
pulmonary reflex was ameliorated by exercise training in 
rabbits with HF (33). Indeed, HF is paralleled by ergoreflex 
overactivity and aerobic exercise training reduced the ab-
normal response to exercise partially due to a reduction of 
ergoreceptor excitation (32).
Since the arterial baroreflex, chemoreflex and cardiopul-
monary reflex control are all integrated in the central nervous 
system and exercise training reestablished the functioning 
of these reflexes, one might suggest that exercise training 
plays an important role in the control of these cardiovascular 
reflexes by the central nervous system. In fact, the impact 
of exercise training on central nervous system control of 
cardiovascular reflexes has been studied (37). Reduced 
AT1 receptors of angiotensin II in the rostral ventrolateral 
Figure 1. Muscle sympathetic nerve activity (MSNA) of a 58-year-old female 
heart failure patient (hypertensive cardiomyopathy) with a 36% ejection fraction 
before and after 4 months of exercise training (ET). MSNA was obtained by 
direct recording of muscle sympathetic discharge by microneurography. Note 
that exercise training dramatically reduced sympathetic discharge. 
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medulla and nucleus tractus solitarii, and normalized ACE 
and ACE2 levels in the brain of HF animal models have 
been proposed as major mechanisms (38).
Impact of exercise training on cardiac 
function
It is widely recognized that aerobic exercise training 
improves cardiac pump capacity. However, the effects of 
aerobic exercise training on cardiac function in HF are still 
controversial. While some studies and a meta-analysis 
(39) failed to show any improvement in cardiac function 
of HF individuals, other studies demonstrated significant 
increased cardiac contractility and function in human 
HF (40). It is important to emphasize that, despite these 
contradictory data, aerobic exercise training does improve 
myocardial blood flow reserve independently of improved 
ventricular function (41). This is of particular interest and 
clinically relevant, since abnormal coronary flow reserve 
can be considered an independent predictor of survival 
in idiopathic dilated cardiomyopathy (42).
Regarding the contradictory results about the effect 
of aerobic exercise training on cardiac function of HF 
individuals, some variables such as aerobic exercise 
training intensity and regimens adopted by each study, 
as well as the methods used to evaluate cardiac func-
tion in human studies, might have influenced the results 
observed. Interestingly, Haykowsky et al. (40) conducted 
a meta-analysis of fourteen studies and observed that 
the exercise intensity adopted in training sessions plays 
an important role in the magnitude of cardiovascular 
adaptation in HF patients. They observed that aerobic 
exercise training sessions performed at intensities above 
60% of VO2 peak are more suitable, leading to improve-
ment of cardiac function in HF patients. In fact, Wisloff 
et al. (43) recently suggested that a threshold intensity 
(at which an exercise session has to be executed) might 
exist to benefit the heart intrinsically. They showed that 
high-intensity interval training (95% of maximal heart 
rate) rather than continuous training (70% of maximal 
heart rate) improved ejection fraction and led to reverse 
left ventricle remodeling (43). This result has been con-
sistently reproduced by these investigators in patients 
with severe cardiac dysfunction. 
In animal models of HF, studies using invasive meth-
odologies demonstrated improved cardiac function by 
aerobic exercise training (17,18), which led to further 
studies focusing on the mechanisms underlying these 
beneficial effects. Ventricular function is tightly coupled 
to Ca2+ transients in the heart. Several Ca2+-handling 
proteins are involved in the maintenance of normal car-
diac Ca2+ homeostasis and contractile function. Among 
these proteins, sarcoplasmic reticulum Ca2+ ATPase 
(SERCA2), ryanodine receptor (RyR), and the Na+/Ca2+ 
exchanger (NCX) are responsible for the balance between 
sarcoplasmic Ca2+ uptake and release, and extrusion by 
sarcolemma, respectively. Abnormal Ca2+ homeostasis by 
perturbation in the expression or function of these major 
Ca2+-regulating proteins has been described in severe 
HF (44). In this context, we have suggested that exercise 
training would improve cardiac function in HF animals 
by, changing, at least in part, the expression of proteins 
involved in cardiac Ca2+ homeostasis. We found that 
exercise training significantly increased fractional shorten-
ing toward normal levels and improved the net balance of 
cardiac Ca2+ proteins involved in Ca2+ transsarcolemmal 
flux and sarcoplasmic reticulum Ca2+ reuptake in a genetic 
model of sympathetic hyperactivity-induced HF based on 
α2A and α2C adrenoceptor gene inactivation in mice (α2A/
α2CARKO) (18). At 7 months of age, when α2A/α2CARKO 
mice display severe HF, exercise training restored cardiac 
NCX expression levels, and increased SERCA2, and 
phosphorylated phospholamban expression levels at both 
residues Ser16 and Thr17, which resulted in improved left 
ventricular function. These findings suggest that the im-
provement in intracellular Ca2+ regulation is a molecular 
mechanism underlying the benefits of exercise training 
for overall ventricular function in severe HF (18).
Accumulated evidence shows that exercise train-
ing is an important strategy not only for the treatment 
but also for the prevention of cardiovascular diseases 
(17). Accordingly, we carried out an investigation to test 
whether exercise training would decrease sympathetic 
activity and delay the onset of ventricular dysfunction 
in α2A/α2CARKO mice (17). To test this hypothesis, we 
studied α2A/α2CARKO mice aged 3-5 months before HF 
was established. We showed that exercise training pre-
vented systolic dysfunction, restored SERCA2 expression 
and the phosphorylation of RyR at Ser2809 to the levels 
of control mice, and increased the phosphorylation of 
phospholamban at Ser16 (17). The reduced expression of 
phospho-Ser2809-RyR in exercise-trained α2A/α2CARKO 
mice toward control levels seems to be beneficial because 
chronic hyperphosphorylation of RyR is associated with 
diastolic Ca2+ leak, leading to arrythmogenicity (45) 
and cardiac dysfunction. In addition, NCX expression 
remained decreased in exercise-trained α2A/α2CARKO 
mice. These results suggest that the mechanisms un-
derlying the improvement of ventricular function include 
the prevention of cardiac Ca2+ handling abnormalities by 
changing the phosphorylation status of proteins involved 
in sarcoplasmic Ca2+ release and reuptake. 
Of interest, our results have been corroborated by 
other investigators studying different animal models of HF 
(46). In addition, enhanced myofilament Ca2+ sensitivity 
induced by exercise training in HF has also been observed 
(47). Taken together, our studies and others suggest the 
preventive and therapeutic effects of exercise training on 
cardiac function by improving Ca2+ homeostasis. The 
summary of the main results is shown in Figure 2.
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Impact of exercise training on cardiac 
remodeling
Pathological cardiac remodeling is an adaptive response of 
the heart to a variety of extrinsic and intrinsic pathophysiological 
stimuli such as sustained neurohumoral activation, mechani-
cal stress and genetic variations. Maladaptative remodeling is 
associated with cardiac dysfunction and HF, where sustained 
hypertrophy is an independent risk factor for HF development 
and sudden death (48). However, not all forms of cardiac hy-
pertrophy are pathological since exercise training promotes a 
physiological cardiac hypertrophy associated with improved 
cardiac function in athletes.
Prolonged neurohumoral activation is the most prominent 
factor associated with pathological cardiac remodeling in HF. In 
fact, we and others have demonstrated that genetic and non-
genetic animal models of neurohumoral overactivation result 
in remarkable maladaptive cardiac remodeling associated 
with ventricular dysfunction (3,4). This concept is supported by 
findings from HF animal models and clinical trials showing that 
inhibition or regression of cardiac hypertrophy by drugs target-
ing neurohumoral systems (i.e., ACE inhibitors and β-blockers) 
lowers the risk for death and HF development (4,9). Over the 
last few years, our group has reported that exercise training 
strikingly counteracts the deleterious effects of neurohumoral 
overactivation in HF. First, we showed that 8 weeks of aerobic 
Figure 2. Effects of exercise training on cardiac function and remodeling. Note that sym-
pathetic hyperactivity in heart failure is linked to altered afferent autonomic control by ar-
terial baroreceptors, cardiopulmonary receptors and chemoreceptors. Additionally, cardiac 
dysfunction and remodeling in heart failure are associated with impaired Ca2+ homeostasis 
by altered expression of Ca2+-handling proteins and myofilament Ca2+ sensitivity, as well as 
activation of the calcineurin/NFAT signaling pathway. Interestingly, exercise training decreases 
sympathetic nerve activity and re-establishes Ca2+ homeostasis, which ultimately contributes 
to improved cardiac function and anti-remodeling. SERCA2 = sarcoplasmic reticulum Ca2+ AT-
Pase; NCX = Na+/Ca2+ exchanger; pPLB-Ser16 and Thr17 = phosphorylated phospholamban 
at both Ser16 and Thr17 residues; pRYR Ser2809 = phosphorylated ryanodyne at the Ser2809 
residue; NFAT = nuclear factor of activated T-cells; PI3K = phosphatidylinositol 3-kinases; Akt 
= protein kinase B. 
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exercise training significantly reduced sympathetic tone with 
a remarkable cardiac anti-remodeling effect in HF mice (18). 
Indeed, exercise training reduced cardiac angiotensin II levels 
by reducing local renin-angiotensin system activation in HF α2A/
α2CARKO mice (21). This phenomenon was accompanied by a 
prominent reduction in both cardiac myocyte width and collagen 
deposition, which resulted in improved ventricular function in 
HF animals. In fact, our group and others have reported that 
aerobic exercise training markedly decreases resting circulating 
neurohormones in HF patients (15), which is one of the most 
valuable indicators of morbidity and mortality. Besides counter-
acting systemic and local neurohumoral hyper-activation in HF, 
exercise training directly benefits the failing heart by promoting 
a notable cardiac anti-remodeling effect.
Exercise training reverses maladaptive cardiac hypertrophy 
and improves ventricular function in HF, a fact that ultimately 
raises the possibility that exercise training actually promotes 
a shift from pathological to physiological cardiac remodeling in 
heart disease (17). Over the last decade, many groups have 
focused on deciphering the cellular basis of exercise training-
induced cardiac anti-remodeling in HF. Among thousands of 
proteins and cellular pathways present in the cardiomyocyte, 
two major signaling cascades have been emerged as key 
regulators of exercise training-associated cardiac hypertrophy 
in HF.
First, the calcineurin/nuclear factor of activated T cell 
(NFAT) signaling cascade, which is the major player in patho-
logical cardiac remodeling, is negatively regulated by exercise 
training (20). Calcineurin is a calcium/calmodulin-activated 
serine-threonine phosphatase that dephosphorylates and 
translocates NFAT transcriptional factors to the nucleus, 
which ultimately activates gene reprogramming and promotes 
maladaptive cardiac hypertrophy. We have first reported that 
aerobic exercise training deactivates the cardiac calcineurin/
NFAT signaling pathway in HF mice, resulting in a significant 
cardiac anti-remodeling effect accompanied by improved ven-
tricular function (20). Of interest, exercise training promoted 
the same beneficial effects as induced by sustained treatment 
with cyclosporine (a selective inhibitor of the calcineurin/NFAT 
pathway) in HF (20). In agreement with our findings, Konhilas 
et al. (49) demonstrated that voluntary exercise decreased 
NFAT activation and reversed cardiac disease phenotypes in an 
animal model of hypertrophic cardiomyopathy. These findings 
clearly demonstrate that deactivation of the calcineurin/NFAT 
signaling pathway is a key process involved in the exercise 
training-induced cardiac anti-remodeling effect in HF.
Unlike the calcineurin/NFAT pathway, the phosphoinosit-
ide-3 kinase/protein kinase B (PI3K/Akt) signaling cascade 
contributes to physiological cardiac remodeling with gain of 
cardiac function (50). Activation of the PI3K/Akt signaling path-
way leads to cardiac hypertrophy by activating and deactivating 
the mammalian target of rapamycin (mTOR) and glycogen 
synthase kinase 3 (GSK-3), respectively. In fact, overexpression 
of an activated form of Akt leads to myocardial hypertrophy with 
improved cardiac function (51), whereas disruption of the Akt-1 
gene abrogates cardiac hypertrophy in response to exercise 
training (52). Kemi et al. (50) demonstrated that changes in the 
cardiac PI3K/Akt signaling pathway distinguished physiological 
from maladaptive cardiac hypertrophy (50). We have recently 
reported that the PI3K/Akt signaling pathway is not required 
to promote exercise training-induced cardiac anti-remodeling 
in HF (20). This result was somehow unexpected, but factors 
such as exercise training intensity and stage of cardiomyopathy 
may contribute to the lack of activation of the PI3K/Akt signaling 
pathway by exercise training in our HF animal model.
Taken together, these findings support the notion that de-
activation and overactivation of maladaptive and physiological 
hypertrophy signaling cascades, respectively, are remarkable 
mechanisms underlying the cardiac anti-remodeling effect of 
exercise training in HF. Therefore, considering the variety of 
cross talking proteins and multiple signaling pathways in cardiac 
cells, additional research is required to better understand the 
effect of exercise training on the vast cellular basis involved in 
maladaptive and physiological cardiac remodeling in HF.
Impact of exercise training on skeletal muscle 
myopathy
Although cardiac dysfunction plays a crucial role in HF 
syndrome, indexes of left ventricular function relate poorly to 
exercise capacity and symptoms, suggesting that the origin of 
HF symptoms may lie elsewhere (53). In fact, skeletal myopathy 
plays a prominent role in HF symptoms since it worsens with 
HF progression and parallels exercise intolerance observed in 
HF individuals (54). In HF, skeletal myopathy affects large and 
small muscles involved in posture, locomotion and respiration. It 
has been characterized by reduced muscle endurance associ-
ated with a pro-oxidant and pro-inflammatory state, nutritional 
disorders, exercise intolerance, mitochondrial dysfunction, 
capillary rarefaction, and altered fiber phenotype with globally 
reduced type I slow twitch and increased type II fast twitch 
fibers (55). Furthermore, changes in excitation-contraction 
coupling and muscle atrophy are also associated with muscle 
dysfunction and reduced strength (55). Taken together, these 
changes contribute to the increased muscle fatigability and 
lactate accumulation in response to exercise in HF. 
Over the last few years, our group has demonstrated that 
sympathetic hyperactivity contributes to skeletal myopathy. 
First, we showed that sympathetic activation contributes to 
chronic vasoconstriction in HF patients at rest and during 
exercise or mental challenge (15). In sympathetic hyperactivity-
induced HF mice, we showed a skeletal muscle pro-oxidant 
state (marked by decreased redox balance and increased 
lipid hydroperoxidation), soleus and plantaris atrophy, capillary 
rarefaction, increased fast/glycolytic fibers, reduced oxidative 
capacity, and exercise intolerance (22).
Aerobic exercise training is a powerful tool counteracting 
skeletal muscle myopathy. It decreased resting sympathetic 
nerve activity paralleled by a significant increased forearm 
blood flow and exercise capacity in HF patients (15). In ani-
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mals, we observed reduced muscle noradrenaline levels and 
oxidative stress associated with improved exercise capacity 
and re-established muscle trophicity (22).
In addition to affecting sympathetic activity, exercise 
training also prevents skeletal muscle abnormalities by other 
mechanisms. The increased content of oxidative enzymes and 
mitochondria induced by aerobic exercise training rescues the 
oxidative capacity, which ultimately leads to an improved VO2 
peak and lactate threshold in animal and human HF (56). The 
peroxisome proliferator-activated receptor γ coactivator-1α 
(PGC-1α) is a key molecule in the regulation of mitochondrial 
biogenesis and its signaling pathway seems to be activated by 
aerobic exercise training (57). Indeed, a reduced inducible nitric 
oxide synthase (iNOS) expression also plays an important role, 
since iNOS-induced intracellular NO accumulation inhibits key 
enzymes of oxidative phosphorylation (22). A summary of the 
main mechanisms involved in the effects of exercise training 
on HF skeletal myopathy is shown in Figure 3.
Figure 3. Effect of aerobic exercise training on heart 
failure-induced skeletal muscle myopathy. Sympathetic 
hyperactivity, reduced blood perfusion and nutritional 
disorders associated with heart failure contribute to skel-
etal muscle myopathy, which is characterized by muscle 
pro-oxidant (increased ROS) and pro-inflammatory (in-
creased pro-inflammatory cytokines such as TNF-α, IL-
1β and IL-6) state associated with contraction dysfunc-
tion and atrophy, weakness, exercise intolerance, and 
early fatigue (A). These responses are associated with 
increased iNOS, increased PGC-1α, mitochondrial dys-
function, impaired Ca2+ handling, apoptosis and reduced 
protein synthesis paralleled by increased proteolysis (A). 
Note that aerobic exercise training counteracts most 
of the mechanisms involved in skeletal myopathy (B). 
ROS = reactive oxygen species; PGC-1α = peroxisome 
proliferator-activated receptor γ coactivator-1α; iNOS = 
inducible nitric oxide synthase; NO = nitric oxide; TNF-α 
= tumor necrosis factor-α; IL-1β = interleukin-1β; IL-6 = 
interleukin-6; IL-10 = interleukin-10; RYR = ryanodyne 
receptor; DHPR = dihydropyridine receptor; SERCA = 
sarcoplasmic reticulum Ca2+ ATPase; T-Tubule = trans-
verse tubule; MHC = myosin heavy chain; P = proteoly-
sis; S = synthesis; IGF-I = insulin-like growth factor-1; 
pFOXO = phosphorylated forkhead family of transcrip-
tion factors; Akt = protein kinase B; Atrogin-1/MAFbx = 
muscle atrophy F-box protein; MuRF-1 = muscle RING-
finger protein-1.
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Alterations in excitation-contraction coupling and protein 
synthesis/degradation balance have also been proposed 
to contribute to skeletal muscle fatigability and weakness 
in HF (Figure 3). In severe HF rats, decreased skeletal 
muscle sarcoplasmic Ca2+ levels were associated with a 
reduced rate of sarcoplasmic reticulum Ca2+ release (58) 
and reuptake (59). This response is partially explained by 
reduced expression of proteins involved in intracellular Ca2+ 
homeostasis in skeletal muscles consisting of different fiber 
types such as soleus and plantaris muscles (predominantly 
oxidative and glycolytic muscles, respectively) (23). Interest-
ingly, we have demonstrated that aerobic exercise training 
improves the net balance of skeletal muscle Ca2+-handling 
proteins in mice (60). Moreover, exercise training restores 
the expression levels of proteins involved in sarcoplasmic 
Ca2+ release and reuptake in soleus and plantaris muscles 
from HF mice (23). This ultimately leads to improved skeletal 
muscle function (23). Regarding skeletal muscle atrophy, 
even aerobic exercise training is able to re-establish soleus 
and plantaris trophicity in our sympathetic hyperactivity-
induced HF mouse model (22,23). This is somewhat sur-
prising since resistance and not aerobic exercise training 
swings the protein synthesis/degradation balance in favor 
of protein synthesis. However, one might consider that, in 
HF, skeletal muscle bulk is reduced and even the aerobic 
exercise stimulus may be enough to abrogate atrophy. 
Nevertheless, aerobic exercise rather than high intensity 
resistance training is recommended for HF patients in view 
of its impact on the hemodynamic responses to exercise. 
The mechanism by which aerobic exercise training prevents/
attenuates skeletal muscle atrophy has not been clarified. 
Activation of the IGF-1/PI3K/Akt signaling pathway is a good 
candidate since it stimulates protein synthesis and aerobic 
exercise training is able to restore decreased muscle IGF-1 
expression in stable HF patients to control subject levels 
(61). In fact, preliminary data from our laboratory point to an 
increased Akt phosphorylation in HF mice after 2 months of 
aerobic exercise training (Bacurau A, unpublished results). 
In addition, aerobic exercise training might reduce protein 
catabolism, which would favor a pro-protein synthesis state. 
Supporting this notion, ongoing studies from our laboratory 
have shown that aerobic exercise training decreases mRNA 
levels of the main skeletal muscle atrophic genes (MuRF 
and Atrogin-1/MAFbx) (Cunha F, unpublished results).
Collectively, our studies and others suggest that aerobic 
exercise training promotes remarkable skeletal muscle 
adaptations in HF that counteract skeletal myopathy. 
Therefore, aerobic exercise training is a powerful non-
pharmacological therapy for HF. 
Taken together, our studies and those of others sug-
gest that sympathetic hyperactivity plays a remarkable 
role in HF syndrome, being associated with cardiac dys-
function and remodeling, as well as skeletal myopathy 
(4,14,15,17,18,22,23). Counteracting sympathetic hyper-
activity is a goal of HF therapy. In this review, we describe 
the effects of aerobic exercise training on sympathetic nerve 
activity, which is reduced in exercise-trained HF patients 
(Figure 1). The reduction of sympathetic hyperactivity by 
aerobic exercise training is extended to our HF mouse 
model and is associated with improved cardiac function 
and reverse remodeling related to a better net balance of 
protein involved in Ca2+ homeostasis and deactivation of 
the calcineurin/NFAT signaling pathway, respectively (Figure 
2). Further studies by our group and others have shown that 
sympathetic hyperactivity contributes to skeletal myopathy 
in HF (22,23). Aerobic exercise training improves skeletal 
muscle function and prevents atrophy, and the mechanisms 
underlying these responses seem to involve reduction of a 
pro-oxidant state, improved Ca2+ homeostasis, mitochon-
drial function, and a synthesis/degradation balance swing 
in favor of protein synthesis (Figure 3). Therefore, aerobic 
exercise training is an efficient non-pharmacological therapy 
for HF and mechanisms underlying its beneficial effects are 
the focus of ongoing studies by our group.
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